Global and United States Decentralized Clinical Trials (DCTs) Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Decentralized clinical trials (DCTs) offer a more patient-centric approach, reflecting a transformational philosophy for the conduct of clinical trials in which fewer clinic visits are required and patient and caregiver burden is reduced. To achieve this, DCTs deploy a wide range of digital technologies to collect safety and efficacy data from study participants, normally from the comfort of the patient’s own home.

The specific digital technologies used for data collection vary by study but can include telemedicine, wearable/sensor devices, eConsent, electronic clinical outcome assessments (eCOA), and electronic health (eHealth) records. Mobile technologies are often used to replace written diaries with electronic diaries and to collect data from wearable sensor devices. In-home services allow the collection of vitals such as blood pressure and blood samples.

Market Analysis and Insights: Global and United States Decentralized Clinical Trials (DCTs) Market
This report focuses on global and United States Decentralized Clinical Trials (DCTs) market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Decentralized Clinical Trials (DCTs) market size is estimated to be worth US$ 8280.7 million in 2022 and is forecast to a readjusted size of US$ 18950 million by 2028 with a CAGR of 14.8% during the review period. Fully considering the economic change by this health crisis, by Type, Interventional Trials accounting for % of the Decentralized Clinical Trials (DCTs) global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Oncology was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Decentralized Clinical Trials (DCTs) market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period.

Global Decentralized Clinical Trials (DCTs) Scope and Market Size
Decentralized Clinical Trials (DCTs) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Decentralized Clinical Trials (DCTs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Decentralized Clinical Trials (DCTs) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Decentralized Clinical Trials (DCTs) market is segmented into
    Interventional Trials
    Observational Trials
    Expanded Access Trials

Segment by Application, the Decentralized Clinical Trials (DCTs) market is segmented into
    Oncology
    Cardiovascular Disease
    Others

Regional and Country-level Analysis
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E

Competitive Landscape and Decentralized Clinical Trials (DCTs) Market Share Analysis
Decentralized Clinical Trials (DCTs) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Decentralized Clinical Trials (DCTs) business, the date to enter into the Decentralized Clinical Trials (DCTs) market, Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:
    ICON Plc
    LEO Innovation Lab
    Science 37
    PRA Health Sciences
    Clinical Ink
    Parexel
    Medable
    Oracle
    CRF Health
    Medidata
    Covance
    IQVIA
    PPD
    PWNHealth, LLC
    Medrio

 1 Study Coverage
    1.1 Decentralized Clinical Trials (DCTs) Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Decentralized Clinical Trials (DCTs) Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Decentralized Clinical Trials (DCTs) Market Size for the Year 2017-2028
        1.2.2 Global Decentralized Clinical Trials (DCTs) Market Size for the Year 2017-2028
    1.3 Decentralized Clinical Trials (DCTs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Decentralized Clinical Trials (DCTs) in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Decentralized Clinical Trials (DCTs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Decentralized Clinical Trials (DCTs) Market Dynamics
        1.4.1 Decentralized Clinical Trials (DCTs) Industry Trends
        1.4.2 Decentralized Clinical Trials (DCTs) Market Drivers
        1.4.3 Decentralized Clinical Trials (DCTs) Market Challenges
        1.4.4 Decentralized Clinical Trials (DCTs) Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Decentralized Clinical Trials (DCTs) by Type
    2.1 Decentralized Clinical Trials (DCTs) Market Segment by Type
        2.1.1 Interventional Trials
        2.1.2 Observational Trials
        2.1.3 Expanded Access Trials
    2.2 Global Decentralized Clinical Trials (DCTs) Market Size by Type (2017, 2022 & 2028)
    2.3 Global Decentralized Clinical Trials (DCTs) Market Size by Type (2017-2028)
    2.4 United States Decentralized Clinical Trials (DCTs) Market Size by Type (2017, 2022 & 2028)
    2.5 United States Decentralized Clinical Trials (DCTs) Market Size by Type (2017-2028)

 3 Decentralized Clinical Trials (DCTs) by Application
    3.1 Decentralized Clinical Trials (DCTs) Market Segment by Application
        3.1.1 Oncology
        3.1.2 Cardiovascular Disease
        3.1.3 Others
    3.2 Global Decentralized Clinical Trials (DCTs) Market Size by Application (2017, 2022 & 2028)
    3.3 Global Decentralized Clinical Trials (DCTs) Market Size by Application (2017-2028)
    3.4 United States Decentralized Clinical Trials (DCTs) Market Size by Application (2017, 2022 & 2028)
    3.5 United States Decentralized Clinical Trials (DCTs) Market Size by Application (2017-2028)

 4 Global Decentralized Clinical Trials (DCTs) Competitor Landscape by Company
    4.1 Global Decentralized Clinical Trials (DCTs) Market Size by Company
        4.1.1 Top Global Decentralized Clinical Trials (DCTs) Companies Ranked by Revenue (2021)
        4.1.2 Global Decentralized Clinical Trials (DCTs) Revenue by Player (2017-2022)
    4.2 Global Decentralized Clinical Trials (DCTs) Concentration Ratio (CR)
        4.2.1 Decentralized Clinical Trials (DCTs) Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Decentralized Clinical Trials (DCTs) in 2021
        4.2.3 Global Decentralized Clinical Trials (DCTs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Decentralized Clinical Trials (DCTs) Headquarters, Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Decentralized Clinical Trials (DCTs) Headquarters and Area Served
        4.3.2 Global Decentralized Clinical Trials (DCTs) Companies Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Decentralized Clinical Trials (DCTs) Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Decentralized Clinical Trials (DCTs) Market Size by Company
        4.5.1 Top Decentralized Clinical Trials (DCTs) Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Decentralized Clinical Trials (DCTs) Revenue by Players (2020, 2021 & 2022)

 5 Global Decentralized Clinical Trials (DCTs) Market Size by Region
    5.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Decentralized Clinical Trials (DCTs) Market Size by Region (2017-2028)
        5.2.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2017-2022
        5.2.2 Global Decentralized Clinical Trials (DCTs) Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Decentralized Clinical Trials (DCTs) Market Size YoY Growth 2017-2028
        6.1.2 North America Decentralized Clinical Trials (DCTs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Decentralized Clinical Trials (DCTs) Market Size YoY Growth 2017-2028
        6.3.2 Europe Decentralized Clinical Trials (DCTs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Decentralized Clinical Trials (DCTs) Market Size YoY Growth 2017-2028
        6.4.2 Latin America Decentralized Clinical Trials (DCTs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Decentralized Clinical Trials (DCTs) Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Decentralized Clinical Trials (DCTs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E

 7 Company Profiles
    7.1 ICON Plc
        7.1.1 ICON Plc Company Details
        7.1.2 ICON Plc Business Overview
        7.1.3 ICON Plc Decentralized Clinical Trials (DCTs) Introduction
        7.1.4 ICON Plc Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.1.5 ICON Plc Recent Development
    7.2 LEO Innovation Lab
        7.2.1 LEO Innovation Lab Company Details
        7.2.2 LEO Innovation Lab Business Overview
        7.2.3 LEO Innovation Lab Decentralized Clinical Trials (DCTs) Introduction
        7.2.4 LEO Innovation Lab Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.2.5 LEO Innovation Lab Recent Development
    7.3 Science 37
        7.3.1 Science 37 Company Details
        7.3.2 Science 37 Business Overview
        7.3.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction
        7.3.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.3.5 Science 37 Recent Development
    7.4 PRA Health Sciences
        7.4.1 PRA Health Sciences Company Details
        7.4.2 PRA Health Sciences Business Overview
        7.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction
        7.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.4.5 PRA Health Sciences Recent Development
    7.5 Clinical Ink
        7.5.1 Clinical Ink Company Details
        7.5.2 Clinical Ink Business Overview
        7.5.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction
        7.5.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.5.5 Clinical Ink Recent Development
    7.6 Parexel
        7.6.1 Parexel Company Details
        7.6.2 Parexel Business Overview
        7.6.3 Parexel Decentralized Clinical Trials (DCTs) Introduction
        7.6.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.6.5 Parexel Recent Development
    7.7 Medable
        7.7.1 Medable Company Details
        7.7.2 Medable Business Overview
        7.7.3 Medable Decentralized Clinical Trials (DCTs) Introduction
        7.7.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.7.5 Medable Recent Development
    7.8 Oracle
        7.8.1 Oracle Company Details
        7.8.2 Oracle Business Overview
        7.8.3 Oracle Decentralized Clinical Trials (DCTs) Introduction
        7.8.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.8.5 Oracle Recent Development
    7.9 CRF Health
        7.9.1 CRF Health Company Details
        7.9.2 CRF Health Business Overview
        7.9.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction
        7.9.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.9.5 CRF Health Recent Development
    7.10 Medidata
        7.10.1 Medidata Company Details
        7.10.2 Medidata Business Overview
        7.10.3 Medidata Decentralized Clinical Trials (DCTs) Introduction
        7.10.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.10.5 Medidata Recent Development
    7.11 Covance
        7.11.1 Covance Company Details
        7.11.2 Covance Business Overview
        7.11.3 Covance Decentralized Clinical Trials (DCTs) Introduction
        7.11.4 Covance Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.11.5 Covance Recent Development
    7.12 IQVIA
        7.12.1 IQVIA Company Details
        7.12.2 IQVIA Business Overview
        7.12.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction
        7.12.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.12.5 IQVIA Recent Development
    7.13 PPD
        7.13.1 PPD Company Details
        7.13.2 PPD Business Overview
        7.13.3 PPD Decentralized Clinical Trials (DCTs) Introduction
        7.13.4 PPD Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.13.5 PPD Recent Development
    7.14 PWNHealth, LLC
        7.14.1 PWNHealth, LLC Company Details
        7.14.2 PWNHealth, LLC Business Overview
        7.14.3 PWNHealth, LLC Decentralized Clinical Trials (DCTs) Introduction
        7.14.4 PWNHealth, LLC Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.14.5 PWNHealth, LLC Recent Development
    7.15 Medrio
        7.15.1 Medrio Company Details
        7.15.2 Medrio Business Overview
        7.15.3 Medrio Decentralized Clinical Trials (DCTs) Introduction
        7.15.4 Medrio Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
        7.15.5 Medrio Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Decentralized Clinical Trials (DCTs) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Decentralized Clinical Trials (DCTs) Market Trends
    Table 3. Decentralized Clinical Trials (DCTs) Market Drivers
    Table 4. Decentralized Clinical Trials (DCTs) Market Challenges
    Table 5. Decentralized Clinical Trials (DCTs) Market Restraints
    Table 6. Global Decentralized Clinical Trials (DCTs) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Decentralized Clinical Trials (DCTs) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Decentralized Clinical Trials (DCTs) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Decentralized Clinical Trials (DCTs) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Decentralized Clinical Trials (DCTs) Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Decentralized Clinical Trials (DCTs) Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Decentralized Clinical Trials (DCTs) Revenue Share by Player, 2017-2022
    Table 13. Global Decentralized Clinical Trials (DCTs) Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Decentralized Clinical Trials (DCTs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trials (DCTs) as of 2021)
    Table 15. Top Players of Decentralized Clinical Trials (DCTs) in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Decentralized Clinical Trials (DCTs) Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Decentralized Clinical Trials (DCTs) Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Decentralized Clinical Trials (DCTs) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Decentralized Clinical Trials (DCTs) Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Decentralized Clinical Trials (DCTs) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Decentralized Clinical Trials (DCTs) Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Decentralized Clinical Trials (DCTs) Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Decentralized Clinical Trials (DCTs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Decentralized Clinical Trials (DCTs) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Decentralized Clinical Trials (DCTs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Decentralized Clinical Trials (DCTs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Decentralized Clinical Trials (DCTs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. ICON Plc Company Details
    Table 31. ICON Plc Business Overview
    Table 32. ICON Plc Decentralized Clinical Trials (DCTs) Product
    Table 33. ICON Plc Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 34. ICON Plc Recent Development
    Table 35. LEO Innovation Lab Company Details
    Table 36. LEO Innovation Lab Business Overview
    Table 37. LEO Innovation Lab Decentralized Clinical Trials (DCTs) Product
    Table 38. LEO Innovation Lab Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 39. LEO Innovation Lab Recent Development
    Table 40. Science 37 Company Details
    Table 41. Science 37 Business Overview
    Table 42. Science 37 Decentralized Clinical Trials (DCTs) Product
    Table 43. Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 44. Science 37 Recent Development
    Table 45. PRA Health Sciences Company Details
    Table 46. PRA Health Sciences Business Overview
    Table 47. PRA Health Sciences Decentralized Clinical Trials (DCTs) Product
    Table 48. PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 49. PRA Health Sciences Recent Development
    Table 50. Clinical Ink Company Details
    Table 51. Clinical Ink Business Overview
    Table 52. Clinical Ink Decentralized Clinical Trials (DCTs) Product
    Table 53. Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 54. Clinical Ink Recent Development
    Table 55. Parexel Company Details
    Table 56. Parexel Business Overview
    Table 57. Parexel Decentralized Clinical Trials (DCTs) Product
    Table 58. Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 59. Parexel Recent Development
    Table 60. Medable Company Details
    Table 61. Medable Business Overview
    Table 62. Medable Decentralized Clinical Trials (DCTs) Product
    Table 63. Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 64. Medable Recent Development
    Table 65. Oracle Company Details
    Table 66. Oracle Business Overview
    Table 67. Oracle Decentralized Clinical Trials (DCTs) Product
    Table 68. Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 69. Oracle Recent Development
    Table 70. CRF Health Company Details
    Table 71. CRF Health Business Overview
    Table 72. CRF Health Decentralized Clinical Trials (DCTs) Product
    Table 73. CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 74. CRF Health Recent Development
    Table 75. Medidata Company Details
    Table 76. Medidata Business Overview
    Table 77. Medidata Decentralized Clinical Trials (DCTs) Product
    Table 78. Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 79. Medidata Recent Development
    Table 80. Covance Company Details
    Table 81. Covance Business Overview
    Table 82. Covance Decentralized Clinical Trials (DCTs) Product
    Table 83. Covance Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 84. Covance Recent Development
    Table 85. IQVIA Company Details
    Table 86. IQVIA Business Overview
    Table 87. IQVIA Decentralized Clinical Trials (DCTs) Product
    Table 88. IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 89. IQVIA Recent Development
    Table 90. PPD Company Details
    Table 91. PPD Business Overview
    Table 92. PPD Decentralized Clinical Trials (DCTs) Product
    Table 93. PPD Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 94. PPD Recent Development
    Table 95. PWNHealth, LLC Company Details
    Table 96. PWNHealth, LLC Business Overview
    Table 97. PWNHealth, LLC Decentralized Clinical Trials (DCTs) Product
    Table 98. PWNHealth, LLC Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 99. PWNHealth, LLC Recent Development
    Table 100. Medrio Company Details
    Table 101. Medrio Business Overview
    Table 102. Medrio Decentralized Clinical Trials (DCTs) Product
    Table 103. Medrio Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million)
    Table 104. Medrio Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Decentralized Clinical Trials (DCTs) Product Picture
    Figure 2. Global Decentralized Clinical Trials (DCTs) Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Decentralized Clinical Trials (DCTs) Market Size 2017-2028 (US$ Million)
    Figure 4. United States Decentralized Clinical Trials (DCTs) Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Decentralized Clinical Trials (DCTs) Market Size 2017-2028 (US$ Million)
    Figure 6. United States Decentralized Clinical Trials (DCTs) Market Share in Global 2017-2028
    Figure 7. Decentralized Clinical Trials (DCTs) Report Years Considered
    Figure 8. Product Picture of Interventional Trials
    Figure 9. Product Picture of Observational Trials
    Figure 10. Product Picture of Expanded Access Trials
    Figure 11. Global Decentralized Clinical Trials (DCTs) Market Share by Type in 2022 & 2028
    Figure 12. Global Decentralized Clinical Trials (DCTs) Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Decentralized Clinical Trials (DCTs) Market Share by Type (2017-2028)
    Figure 14. United States Decentralized Clinical Trials (DCTs) Market Share by Type in 2022 & 2028
    Figure 15. United States Decentralized Clinical Trials (DCTs) Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Decentralized Clinical Trials (DCTs) Market Share by Type (2017-2028)
    Figure 17. Product Picture of Oncology
    Figure 18. Product Picture of Cardiovascular Disease
    Figure 19. Product Picture of Others
    Figure 20. Global Decentralized Clinical Trials (DCTs) Market Share by Application in 2022 & 2028
    Figure 21. Global Decentralized Clinical Trials (DCTs) Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Decentralized Clinical Trials (DCTs) Market Share by Application (2017-2028)
    Figure 23. United States Decentralized Clinical Trials (DCTs) Market Share by Application in 2022 & 2028
    Figure 24. United States Decentralized Clinical Trials (DCTs) Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Decentralized Clinical Trials (DCTs) Market Share by Application (2017-2028)
    Figure 26. North America Decentralized Clinical Trials (DCTs) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Decentralized Clinical Trials (DCTs) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Decentralized Clinical Trials (DCTs) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Decentralized Clinical Trials (DCTs) Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. ICON Plc Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 55. LEO Innovation Lab Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 56. Science 37 Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 57. PRA Health Sciences Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 58. Clinical Ink Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 59. Parexel Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 60. Medable Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 61. Oracle Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 62. CRF Health Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 63. Medidata Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 64. Covance Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 65. IQVIA Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 66. PPD Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 67. PWNHealth, LLC Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 68. Medrio Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed

Decentralized clinical trials (DCTs) offer a more patient-centric approach, reflecting a transformational philosophy for the conduct of clinical trials in which fewer clinic visits are required and patient and caregiver burden is reduced. To achieve this, DCTs deploy a wide range of digital technologies to collect safety and efficacy data from study participants, normally from the comfort of the patient’s own home.

The specific digital technologies used for data collection vary by study but can include telemedicine, wearable/sensor devices, eConsent, electronic clinical outcome assessments (eCOA), and electronic health (eHealth) records. Mobile technologies are often used to replace written diaries with electronic diaries and to collect data from wearable sensor devices. In-home services allow the collection of vitals such as blood pressure and blood samples.

Market Analysis and Insights: Global and United States Decentralized Clinical Trials (DCTs) Market
This report focuses on global and United States Decentralized Clinical Trials (DCTs) market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Decentralized Clinical Trials (DCTs) market size is estimated to be worth US$ 8280.7 million in 2022 and is forecast to a readjusted size of US$ 18950 million by 2028 with a CAGR of 14.8% during the review period. Fully considering the economic change by this health crisis, by Type, Interventional Trials accounting for % of the Decentralized Clinical Trials (DCTs) global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Oncology was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Decentralized Clinical Trials (DCTs) market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period.

Global Decentralized Clinical Trials (DCTs) Scope and Market Size
Decentralized Clinical Trials (DCTs) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Decentralized Clinical Trials (DCTs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Decentralized Clinical Trials (DCTs) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Decentralized Clinical Trials (DCTs) market is segmented into
    Interventional Trials
    Observational Trials
    Expanded Access Trials

Segment by Application, the Decentralized Clinical Trials (DCTs) market is segmented into
    Oncology
    Cardiovascular Disease
    Others

Regional and Country-level Analysis
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E

Competitive Landscape and Decentralized Clinical Trials (DCTs) Market Share Analysis
Decentralized Clinical Trials (DCTs) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Decentralized Clinical Trials (DCTs) business, the date to enter into the Decentralized Clinical Trials (DCTs) market, Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:
    ICON Plc
    LEO Innovation Lab
    Science 37
    PRA Health Sciences
    Clinical Ink
    Parexel
    Medable
    Oracle
    CRF Health
    Medidata
    Covance
    IQVIA
    PPD
    PWNHealth, LLC
    Medrio